AAAAAA

   
Results: 1-3 |
Results: 3
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized,double-blind, placebo-controlled trial
Authors: Littlewood, TJ Bajetta, E Nortier, JWR Vercammen, E Rapoport, B
Citation: Tj. Littlewood et al., Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized,double-blind, placebo-controlled trial, J CL ONCOL, 19(11), 2001, pp. 2865-2874
Role of oral versus IV iron supplementation in the erythropoietic responseto rHuEPO: a randomized, placebo-controlled trial
Authors: Olijhoek, G Megens, JGN Musto, P Nogarin, L Gassmann-Mayer, C Vercammen, E Hayes-Licitra, SA
Citation: G. Olijhoek et al., Role of oral versus IV iron supplementation in the erythropoietic responseto rHuEPO: a randomized, placebo-controlled trial, TRANSFUSION, 41(7), 2001, pp. 957-963
Comparative pharmacokinetics, safety, and tolerability after subcutaneous administration of recombinant human erythropoietin formulated with different stabilizers
Authors: Cheung, WK Natarajan, J Sanders, M Vercammen, E
Citation: Wk. Cheung et al., Comparative pharmacokinetics, safety, and tolerability after subcutaneous administration of recombinant human erythropoietin formulated with different stabilizers, BIOPHARM DR, 21(6), 2000, pp. 211-219
Risultati: 1-3 |